UROFOLLITROPIN for Ovulation induction: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 37 adverse event reports in the FDA FAERS database where UROFOLLITROPIN was used for Ovulation induction.
Most Reported Side Effects for UROFOLLITROPIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Ovarian hyperstimulation syndrome | 73 | 72.3% | 1 | 66 |
| Abdominal distension | 25 | 24.8% | 0 | 21 |
| Abdominal pain | 20 | 19.8% | 0 | 16 |
| Ascites | 13 | 12.9% | 0 | 13 |
| Nausea | 12 | 11.9% | 0 | 11 |
| Chest discomfort | 10 | 9.9% | 0 | 8 |
| Dyspnoea | 10 | 9.9% | 0 | 10 |
| Vomiting | 10 | 9.9% | 0 | 8 |
| Oliguria | 7 | 6.9% | 0 | 7 |
| Off label use | 5 | 5.0% | 0 | 4 |
| Pelvic fluid collection | 5 | 5.0% | 0 | 5 |
Other Indications for UROFOLLITROPIN
In vitro fertilisation (26)
Assisted reproductive technology (7)
Product used for unknown indication (7)
Infertility (6)
Other Drugs Used for Ovulation induction
CHORIOGONADOTROPIN ALFA (460)
FOLLITROPIN (249)
CLOMIPHENE (124)
LETROZOLE (122)
MENOTROPINS (107)
FOLLITROPIN BETA (86)
LUTROPIN ALFA (86)
TRIPTORELIN (73)
LEUPROLIDE (64)
GONADOTROPHIN, CHORIONIC (57)